Bengt Simonsson

18.0k total citations · 1 hit paper
157 papers, 5.5k citations indexed

About

Bengt Simonsson is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Bengt Simonsson has authored 157 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Hematology, 76 papers in Genetics and 30 papers in Immunology. Recurrent topics in Bengt Simonsson's work include Chronic Lymphocytic Leukemia Research (71 papers), Chronic Myeloid Leukemia Treatments (61 papers) and Acute Lymphoblastic Leukemia research (27 papers). Bengt Simonsson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (71 papers), Chronic Myeloid Leukemia Treatments (61 papers) and Acute Lymphoblastic Leukemia research (27 papers). Bengt Simonsson collaborates with scholars based in Sweden, United States and Germany. Bengt Simonsson's co-authors include B Smedmyr, François Guilhot, Rüdiger Hehlmann, Michele Baccarani, Hans Hagberg, Gunnar Öberg, Clas F. R. Källander, Martin Höglund, Richard A. Larson and Mats Bengtsson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bengt Simonsson

154 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

2009 890 citations Jörge E. Cortes, François Guilhot et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bengt Simonsson Sweden	35	3.8k	2.9k	1.4k	1.1k	825	157	5.5k
Bruno Varet France	37	4.1k 1.1×	2.6k 0.9×	1.0k 0.7×	1.4k 1.3×	445 0.5×	145	7.6k
Hirohisa Nakamae Japan	29	3.6k 0.9×	2.1k 0.7×	1.2k 0.9×	1.2k 1.1×	683 0.8×	271	5.1k
Richard Szydlo United Kingdom	50	6.1k 1.6×	3.4k 1.2×	1.8k 1.3×	2.0k 1.9×	1.1k 1.3×	197	8.7k
F Bauters France	45	5.2k 1.4×	3.0k 1.1×	610 0.4×	1.4k 1.3×	721 0.9×	211	7.3k
Giuseppe Visani Italy	45	4.0k 1.0×	2.0k 0.7×	462 0.3×	1.4k 1.3×	981 1.2×	285	6.6k
Giuliana Alimena Italy	34	3.6k 0.9×	2.1k 0.7×	975 0.7×	667 0.6×	1.1k 1.3×	206	4.7k
Françoise Huguet France	39	5.6k 1.4×	3.2k 1.1×	1.6k 1.2×	1.7k 1.6×	2.7k 3.3×	179	8.0k
Gianantonio Rosti Italy	38	5.6k 1.5×	4.4k 1.5×	2.7k 2.0×	924 0.9×	820 1.0×	215	6.6k
Martin Höglund Sweden	37	3.4k 0.9×	1.6k 0.6×	570 0.4×	1.2k 1.1×	1.1k 1.4×	134	5.1k
Sigurður Y. Kristinsson Sweden	46	3.9k 1.0×	2.6k 0.9×	597 0.4×	1.6k 1.5×	353 0.4×	142	6.0k

Countries citing papers authored by Bengt Simonsson

Since Specialization

Citations

This map shows the geographic impact of Bengt Simonsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Simonsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Simonsson more than expected).

Fields of papers citing papers by Bengt Simonsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Simonsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Simonsson. The network helps show where Bengt Simonsson may publish in the future.

Co-authorship network of co-authors of Bengt Simonsson

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Simonsson. A scholar is included among the top collaborators of Bengt Simonsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Simonsson. Bengt Simonsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hehlmann, Rüdiger, Jörge E. Cortes, Teresa Zyczynski, et al.. (2018). Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY. American Journal of Hematology. 94(1). 46–54. 33 indexed citations

Söderlund, Stina, Lisa Christiansson, Inger Persson, et al.. (2016). Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. Leukemia Research. 50. 95–103. 20 indexed citations

Paquette, Ronald, Bengt Simonsson, Elisabetta Abruzzese, et al.. (2015). CARDIOVASCULAR (CV)-RELATED HOSPITALIZATION IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY. Haematologica. 100. 437–437. 2 indexed citations

Simonsson, Bengt, Henrik Hjorth‐Hansen, Ole Weis Bjerrum, & Kimmo Porkka. (2011). Interferon alpha for Treatment of Chronic Myeloid Leukemia. Current Drug Targets. 12(3). 420–428. 20 indexed citations

Porkka, Kimmo, Satu Mustjoki, & Bengt Simonsson. (2009). Suboptimal responses in chronic myeloid leukemia: milestones and mechanisms. Expert Review of Hematology. 2(1). 81–91. 3 indexed citations

Mustjoki, Satu, Marja Ekblom, T. Petteri Arstila, et al.. (2009). Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia. 23(8). 1398–1405. 229 indexed citations

Olsson‐Strömberg, Ulla, Anna Åleskog, Martin Höglund, et al.. (2006). Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. Anti-Cancer Drugs. 17(6). 631–639. 3 indexed citations

Simonsson, Bengt, O. Kloke, & R. Stahel. (2005). ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML). Annals of Oncology. 16. i52–i53. 10 indexed citations

Schmitz, Norbert, Per Ljungman, Charlotte Cordonnier, et al.. (2004). Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial. Bone Marrow Transplantation. 34(11). 955–962. 40 indexed citations

10.

Löfgren, Christina, Christer Paul, Maria Åström, et al.. (2004). Granulocyte‐macrophage colony‐stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. British Journal of Haematology. 124(4). 474–480. 24 indexed citations

11.

Abboud, CN, et al.. (1999). Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex. Bone Marrow Transplantation. 24(10). 1057–1063. 10 indexed citations

12.

Pauksen, Karlis, et al.. (1998). Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients. Bone Marrow Transplantation. 22(1). 67–71. 34 indexed citations

13.

Thunberg, Ulf, Britt Thuresson, Jan Westin, et al.. (1997). Presence of clonal cells in all stem cell enriched grafts in transplanted multiple myeloma.. Blood. 90. 218. 1 indexed citations

14.

Höglund, Martin, B Smedmyr, Mats Bengtsson, et al.. (1997). Mobilization of CD34+ cells by glycosylated and nonglycosylated G‐CSF in healthy volunteers — a comparative study. European Journal Of Haematology. 59(3). 177–183. 55 indexed citations

15.

Arvidson, Johan, Kristina Carlson, H Hagberg, et al.. (1994). Pulmonary function after autologous bone marrow transplantation in children.. PubMed. 14(1). 117–23. 26 indexed citations

16.

McGlave, Philip B., Paolo de Fabritiis, A. B. Deisseroth, et al.. (1994). Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. The Lancet. 343(8911). 1486–1488. 135 indexed citations

17.

Carlson, Kristina, Bengt Simonsson, & Sverker Ljunghall. (1994). Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcified Tissue International. 55(6). 408–411. 40 indexed citations

18.

Rowe, Jacob M., et al.. (1993). Treatment of Minimal Residual Diseasein Myeloid Leukemia—The Immunotherapeutic Options with Emphasis on Linomide. Leukemia & lymphoma. 11(5-6). 321–329. 15 indexed citations

19.

Smedmyr, B, Mats Bengtsson, Å. Jakobsson, et al.. (1991). Regeneration of CALLA (CD10⁺), TdT⁺ and double‐positive cells in the bone marrow and blood after autologous bone marrow transplantation. European Journal Of Haematology. 46(3). 146–151. 21 indexed citations

20.

Hartvig, Per, Bengt Simonsson, Göran Berg, Inger Wallin, & Hans Ehrsson. (1988). Inter- and intraindividual differences in oral chlorambucil pharmacokinetics. European Journal of Clinical Pharmacology. 35(5). 551–554. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact